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ABSTRUCT
     The differences of the growth rate of MH 134 tumor inoculated in younger or older 
mice were experimentally investigated in this study. The age-related tumor growth rate 
were evaluated as the changes of a tumor size to food pad ratio respectively. 
     In this study, a 6 weeks-old, a 9 weeks-old and a 20 weeks-old C3H/He mice 
were correctly selected and prepared according to age. From the aspect of age factor in 
tumorbearing host, MH 134 tumor growth rate as well as survival rate after inoculation of 
2.5 x 104, 2.5 x 105 and 2.5 x 106 tumor cells were simulatenously investigated in each age 
groups. 
     Interestingly enough, a depressed tumor growth rate was noted in older mice in 
comparison with those in younger mice, whereas survival rates showed almost the same 
between in younger and older mice groups. 
     While as many as 2.5 x 106 of MH 134 tumor cells were inoculated, the differences 
in tumor growth rate between younger and older mice were apparently pronounced. The 
rapid tumor growth in young mice, furthermore, were definitely denoted. Meanwhile, the 
improvement of survival rate in older mice had not become manifest regardless of slow 
growth, as compared in the two age group. Age affected some aspect of inhibitory tumor 
growth, whereas this assumption was not consistent with prolongation of survival time. 
     This results reported here ensured the differences of tumor growth rate in tumor-
bearing host concerning age. Needless to say, the reliability of tumor resection as a 
treatment against cancer has been substantiated even for the elderly patients in order to 
enable survival rate significantly improve.
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                   INTRODUCTION 
     According to acutual prolongation of life span, the high incidence of variou s 
kinds of carcinoma has been notably approved in the elderly'). The favorable effects o f 
treatments for cancer are facilitated by a combination of therapeutic procedures with 
surgery, radiation, chemotherapy and immunotherapy. However, it is well conceived 
that the most favorable results of cancer treatments are mainly obtained by surgical 
excision agaist cancerous tumor. In an attempt to the -'achievement 'of further extension 
of surgical indication, it is on these premises that the operative risk should be eliminated 
and subsequently a satisfactory outcome following surgery should be ensured even i n 
elderly patients. 
     It is generally accepted that a high frequency of cancer is observed with advencing 
age and a growth rate of cancer tumor in the elderly is considerably inhibited as 
compared to that in the younger. 
     However, a relatively little information is found in terms of the difference of tumor 
growth rate between younger and older patients. This study was undertaken to elucidate 
the specificity of tumor growth patterns in the advancing age experimentally. 
               MATERIAL AND METHODS 
     The animals used were 6 week-old, 9 week-old and 20 week-old c3H/HE mice 
respectively that have been supplied by chugai Laboratory, Tokyo. The suspension of 
tumor cell of MH 134 was prepared by ascites from tumor-bearing mouse and viable 
tumor cells were counted in a hemacytometer by the trypan blue staining method. The cell 
suspension with Hank's medium containing 5 % fetal calf serum was adjusted to the 
concentration of 106 tumor cell in 10,ul of this suspension. 
     This suspension containing 2.5 x 106, 2.5 x 105 and 2.5 x 104 of MH 134 tumor cells 
were inoculated in food pad in divided three groups which were selected according to 
mice age of 6 week-old, 9 week-old and 20 week-old respectively. 
     We has assumed as a experimental protocol that 6 and 9 week-old mice would be 
the representative state of young person immunologically as well as 20 week-old mice 
would be those of advancing age. We have studied on changes of inoculated tumor 
growth rate in individual each groups, which were expressed with the ratio of a diameter 
of tumor mass to a width of food pad. 
     Eighteen mice in each groups, which were divided into three groups of 6 week-
old, 9 week-old and 20 week-old according to mouse age, were prepared and a total 
of fifty-four mice were subjected to this study. Furthermore, eighteen mice in three 
groups were separated by inoculation of 2.5X106, 2.5X 105 and 2.5 x 104 tumor cells 
respectively. (Fig 1) 
     The observation of tumor growth rate as well as survival period were continued to 
record up to death of tumor-bearing mice in comparision with those of each three
Fig 1. Tumor mass of MH 134 on 7th day after inoculation of 2.5 x 106 
      tumor cells according to mice age (right : 6 week-old, middle 
       9 week-old, left: 20 week-old)
groups to certify the influencing age effect of tumor-bearing mouse and the number 
factor of inoculated tumor cells. The tumor growth rate after inoculation was calculated 
by a ratio of tumor area to food pad.. 
                     RESULTS 
     The survival rate was investigated according to number of inoculated tumor cells 
in each groups divided by mouse age. The mice with inoculation of MH 134 tumor 
cells of 2.5 x 106 expired in relatively early period as compared with those of 2.5 x 105
Fig 2. Survival after inoculation of MH 134 tumor cells of 2.5x 106 2.5 x 104 
       and 2.5 x 104 according to meic age.
and 2.5 x 104 as shown in Fig 2. 
     In comparision with survival rate, it was elucided that the survival period was 
approximately proportion to number of inoculated tumor cells in each three groups. 
However, survival in younger mice were directly influenood on number of inoculated 
tumor cells while survival rate in older mice were not necessarily similar to those in 
younger mice. 
      As far as we can observe, it is of interest to note that prolonged survival with 
inoculated tumor growth are more likely to obtain old mice rather than in young mice. 
It is shown that a large number of inoculation of MH 134 tumor cells makes survival 
reduce in younger mice, while its tendency is discordant in aged mice so that a less 
number of inoculation of MH 134 tumor cells may allow to bring about the longer 
survival in younger mice. 
     When 2.5 x 106 of MH 134 tumor cells were inoculated, the ensuing tumor size 
was considerably enhanced with the elapse of time, especially after 14 days of inocula-
tion as compared with inoculation of more or less a small number of 2.5 x 105 and 2.5 x 
104 MH 134 tumor cells. In the series of MH 134 inoculation, the rapid tumor growth 
was noted in younger mice rather than in older mice regardless of inoculated number 
of MH 134 tumor cells. 
     However, the difference of tumor growth rate between younger and older mice
Fig 3. Tumor growth rate inoculated MH 134 tumor cells of 2.5X101 
       according to age.
Fig 4. Tumor growth rate inoculated MH 134 tumor cells of 2.5 x 105 
       according to age.
were extremely defined at inoculation of 2.5 X 106, 2.5 x 105 and 2.5 x 104 tumor cells as 
outlined in Fig 3. 4. 5. As compared to inoculation of 2.5x101 and 2.5X 104 tumor 
cells, the increased tumor sizes were significantly enhanced in young mice of 6 week-
old although those in old mice of 20 week-old as well as 9 week-old mice were 
apparently suppressed. 
     As shown in Fig 5, a less depressed tumor size were observed at inoculation of 
2.5 x 104 tumor cells, demonstrating a minimal difference in regard to age. 
     As indicated in Fig 5, the inoculation of a small number of 2.5 x 104 tumor cells 
brought about the depression of tumor growth rate. From the observation of changes in 
tumor size, the changes of inoculated tumor sizes were markedly increased in younger 
mice whenever 2.5 X 106, 2.5 X 105 and 2.5 X 104 tumor cells were inoculated. 
     In group of 6 week-old mice, the tumor growth rates were rapidly enhanced as 
compared to those of other groups, especially its modality of tumor growth was charac-
terized after 2 weeks of MH 134 tumor cells inoculation. In groups of either 9 week-
old or 20 week-old mice, the patterns of tumor growth were moderately depressed 
during the course of this study in comparision with that of 6 week-old mice group.
Fig 5. Tumor growth rate inoculated MH 134 tumor cells of 2.5 x 104 
       according to age.
     The growth rate of tumor cells inoculated in older mice were obviously slow despite 
the demonstration of rapid growth in young mice. Interestingly enough, it is of note 
that the patterns of tumor growth rate were inversely proportinal to immunological 
responsiveness which might appearently be suppressed in older mice. 
                    DISCUSSION 
     With advancing age, a high incidence of occurrence of various kinds of carcinoma 
has undoubtedly noted in all parts of body." On recent advances in cancer therapy, it is 
speculated that the first aim to achieve the ensuing excellent outcome for cancer treatment 
is large enough to remove tumor mass surgically. In addition, it is generally conceded 
that surgical excision for cancer is refractory to a gain of satisfactory results as compared 
to that of any other intensively therapeutic procedures. There is not doubt that surgical 
resection against carcinoma is considered best suited for management of cancer3>4> .
     This study is to certify the reliability of operative treatment even in the aged 
patients without some of an apprecial risk for surgery in comparision with survival and
tumor growth in relation to age of tumor-bearing host. 
     As far as we consider in relation to aspect of life span in tumor-bearing mice, 
it is assumed that likelihood of survival in older tumor-bearing mice is inferior to that in 
younger mice. 
     However, it is of interst to note from this study, contrary to what others believe, 
that old tumor-bearing enable their survival rate far prolong. From these results, it 
seems worthwhile to document that host resistence in older mice against MH 134 tumor 
growth is strong enough as compared with that in younger mice. 
     Furthermore, it was experimentally defined that tumor growth rate was relatively 
depressed in older mice. However, it was concluded that these results did not lead 
better prognosis in older mice rather than in younger mice in comparative study with 
special reference to survival period. These experimental results, furthermore, show clinical 
reliability of enlarging the operative indication for the aged patients under less appre-
ciably operative risk to obtain a further excellent cure rate even in older patients. This 
study also provides an experimental evidence of the specific behavor in MH 134 tumor 
growth inoculated in old mice as compared to those in young mice, namely, tumor growth 
rate is enhanced in young tumor-bearing host rather than in old tumor-bearing host 
and its tendency has become manifest at the time of inoculation of a large number of 
2.5 x 106 tumor cells, on the contrary, it enables survival shorten notably in younger mice. 
     By comparative study in terms of growth rate of MH 134 tumor cells inoculated in 
either older or younger mice, it has been argued that MH 134 tumor growth was apparently 
depressed in older mice but it was not responsible for improvement of survival rate. 
     Insofar as increasing size of inoculated tumor mass, prolonged survival is unable 
to be expected regardless of age in tumor-bearing host. However, it is well conceived, 
otherwise, that the prognosis in older patients with cancer is relatively fair, as a 
consequence of slow tumor growth as compared to those in younger tumor-bearing host 
in which tumor growth are prevalent with fashion of far malignant potential. It is 
emphasized as a result of this experimental study that surgical excision is enough to 
permit a favorable outcome for cancer treatment even in older patients unless it is 
otherwise contraindicated. 
                             REFERENCE 
     1) CAROSELLA, E. D., et al : Rosette-forming T cell in human peripharal blood at 
       different age. Cellular Immunology, 12 : 323, 1974. 
     2) EILBER, F. R., et al: Impaired immunologic reactivity and recurrence following cancer 
        surgery, Cancer, 25: 362, 1970. 
     3) JONES, J. C. , et al: Primary carcinoma of the lung. A follow up study including 
        pulmonary function Studies of long time survivors, J. Thoracic Cardiovasc. Surg., 39: 
       144, 1960. 
     4) BousHY, S. F., et al : Clinical, physiologic and morphologic examination of the lung 
        in patients with bronchogenic carcinoma and the relation of the findings to postoperative
        death. Am Rev.. Resp Dis., 101 : 685, 1970.
